Back to search
Systemic Vascular Resistance
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Systemic Vascular Resistance trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Systemic Vascular Resistance trials you may qualify forArterial hypertension (AH) has been identified as an important public health problem and considered a new epidemic with high mortality and morbidity. High blood…
This is an exploratory, open-label, single-arm Phase 1 clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of QT-219C. QT-219…
Raynaud's phenomenon is a condition where the blood vessels in participants fingers and toes get too narrow when cold or stressed. This makes participants finge…
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated autoimmune disease.
This is a study to evaluate safety and effectiveness of Ilaris in adult and pediatric patients receiving the drug in a clinical setting for any of the following…
The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with othe…
Septic shock is one of the most frequent reasons for admission to intensive care units and remains associated with a high mortality rate of approximatively 40%…
Systemic arterial hypertension is a serious health problem worldwide. In some cases, it can phenotypically present as resistant arterial hypertension, which con…